Literature DB >> 30953310

Human genome-derived TOP1 matrix attachment region enhances transgene expression in the transfected CHO cells.

Yan-Long Jia1,2, Xiao Guo1,2, Xi-Cheng Wang1,2, Tian-Yun Wang3,4.   

Abstract

OBJECTIVES: To investigate the effect of full-length fragment of DNA topoisomerase I gene (TOP1) matrix attachment regions (MARs) originating from the human genome on transgene expression in Chinese hamster ovary (CHO) cells and explore the underlying mechanisms.
RESULTS: Results showed that TOP1 MAR cannot only enhance the transient and stable transgenic expression of enhanced green fluorescence protein (EGFP) but also increase long-term stability and ratio of positive colonies in transfected CHO cells with TOP1 MAR at the 5' or 3' ends of the EGFP expression cassette. Interestingly, the CHO cells were transfected with the 5',3' TOP1 MAR-containing vector featured the highest transient and stable expression, whereas those with the 3' TOP1 MAR-containing vector exhibited the most effective stability and ratio of positive colonies. We also observed that transgene copy numbers and mRNA of egfp gene were correlated with the expression levels of EGFP protein in polyclonal CHO cells. However, the heterogeneity of expression in monoclonal CHO cells was unaffected by transgene copy number.
CONCLUSIONS: The findings may aid in the potential application of TOP1 MAR in expression enhancement of recombinant proteins in mammalian cells.

Entities:  

Keywords:  Chinese hamster ovary cells; Human DNA topoisomerase I gene (TOP1); Matrix attachment region (MAR); Transgene expression

Mesh:

Substances:

Year:  2019        PMID: 30953310     DOI: 10.1007/s10529-019-02673-7

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  1 in total

1.  Enhanced transgene expression using two β-globin MARs flanking expression cassettes in stably transfected CHO-K1 cells.

Authors:  Jihong Zhang; Junhe Zhang; Shan Cheng; Wenwen Yang; Shijiang Li
Journal:  3 Biotech       Date:  2019-11-02       Impact factor: 2.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.